EpiBiologics
PrivateLast Round
Series B
Jan 8, 2026
Total Funding Raised
$310M
Company Overview
EpiBiologics is a biotechnology company that develops protein degradation therapeutics aimed at addressing the root causes of disease biology through antibody-based targeted therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiBiologics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EpiBiologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 8, 2026 | ||||
| Series B | Jan 8, 2024 | ||||
| Series A Extension | Jul 20, 2023 | ||||
| Series A | Mar 22, 2023 |
Key People
Founding team and executive leadership
EpiBiologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series B |
| Codon Capital | Series B, Series A, Series A Extension |
| GV | Series B, Series A Extension, Series A |
| Digitalis Ventures | Series B, Series A Extension, Series A |
| Taiho Ventures | Series B, Series A Extension, Series A |
| Mubadala Capital | Series A |
| Mission BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Developing an experimental protein-destroying antibody for clinical trials.
- Jan 8, 2024
$107M round raised
EpiBiologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiBiologics's valuation, stock price, and market status.